Latest news
Clinical Trials Insights
AbbVie announces positive topline results from the phase 3 trial showing Etentamig significantly improved response rate and progression-free survival in patients with relapsed/refractory multiple...
AbbVie has announced positive topline results from a phase 3 study evaluating etentamig, an investigational BCMA x CD3 bispecific T-cell engager, versus standard available therapies (SAT)...
Drug Discovery & Development
Kali Therapeutics Receives US FDA Clearance for KT501 Investigational New Drug Application
The US Food and Drug Administration (FDA) has cleared Kali Therapeutics, a clinical-stage biotechnology company pioneering next-generation immune-resetting and multi-specific therapies, Investigational New Drug...
Drug Delivery and Supply Chain
InnovHeart announces first US Saturn transseptal TMVR system implant, reaching 15 patients globally
InnovHeart, a medical device company developing the Saturn Transseptal Transcatheter Mitral Valve Replacement (TMVR) System, today announces the successful implantation of the first US...
Drug Delivery and Supply Chain
Cipla announces exclusive partnership with Qilu Pharmaceutical for the licensing and supply of biosimilar to Keytruda (Pembrolizumab) in the US
Invagen Pharmaceuticals has entered into a strategic partnership with Qilu Pharmaceutical Co, for the exclusive licensing and supply of QL2107, a biosimilar to Keytruda (pembrolizumab), for...
Pharma in Healthcare
American Regent issues voluntary nationwide recall of three lots of epinephrine injection, due to the presence of particulate matter and lack of assurance of...
American Regent is conducting a nationwide voluntary recall of three lots of epinephrine injection, USP 30 mg/30 mL (1 mg/mL) multi dose vials to the...
Drug Discovery & Development
Thryv Therapeutics licences a new class of SGK1 inhibitors from Spain’s CSIC and Universidad Autónoma de Madrid, extending its platform into neurodegenerative disease
Thryv Therapeutics has entered into an exclusive, worldwide, royalty-bearing patent and know-how license agreement with the Spanish National Research Council (Consejo Superior de Investigaciones...
Drug Delivery and Supply Chain
ENA Respiratory awarded Biointelect Venturer funding to support new study in asthma patients of INNA-051 nasal spray designed to protect against symptomatic viral respiratory infections
ENA Respiratory, a clinical-stage pharmaceutical company developing host defence enhancers for the prevention of complications associated with respiratory viral infections in at-risk populations, has been awarded AUD...
Lubrizol will showcase its portfolio of multifunctional excipients at CPHI Milan (6-8 October), and demonstrate how they solve diverse drug delivery challenges.
Visitors to stand...
Leading African biopharmaceutical company Minapharm Group, headquartered in Egypt with subsidiaries in Berlin, will receive up to US$16.5 million from the Coalition for Epidemic Preparedness...
Clinical Trials Insights
NRG Therapeutics presents data on lead clinical asset NRG5051 confirming novel disease-modifying approach to ALS
NRG, an innovative clinical stage neuroscience company targeting a novel mechanism to restore mitochondrial dysfunction in neurodegenerative diseases, today presented a poster on preclinical...
Clinical Trials Insights
VarmX enrols first participant in global phase 3 trial evaluating VMX‑C001 in urgent surgery
VarmX, a biotech company developing innovative approaches to bypass direct oral anticoagulants targeting activated factor Xa (FXa inhibitors), enrolled the first participant in its global phase 3...
Drug Delivery and Supply Chain
Aurora Cannabis furthers global medical cannabis growth with accretive acquisition of Internode Pharma and HAP Pharma
Aurora Cannabis, the Canadian-based leading global medical cannabis company, has acquired Internode Pharma, a licensed importer and wholesaler and HAP Pharma, a licensed pharmacy.
Strategic rationale
• The UK...
Drug Discovery & Development
FairJourney Bio delivers antibody engineering for novel tumour-conditional IL-12 therapeutic approach that unlocks the potential of localised cytokine activation
FairJourney Bio, a global antibody discovery expert, has announced the publication of a peer-reviewed study in mAbs describing a novel approach with the potential to...
Drug Delivery and Supply Chain
FUJIFILM Biotechnologies selected in FDA precheck pilot programme to advance US drug manufacturing
Fujifilm’s commercial-scale cell culture manufacturing facility in Holly Springs, North Carolina, has been selected as one of only seven participants in the US Food...
Drug Delivery and Supply Chain
Taysha Gene Therapies and Catalent expand strategic partnership to include future commercial manufacturing support of TSHA-102 gene therapy for Rett syndrome
Taysha Gene Therapies, a clinical-stage biotechnology company focused on developing adeno-associated virus (AAV)-based gene therapies for rare, monogenic diseases of the central nervous system,...
Drug Delivery and Supply Chain
Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across US, Europe and India
Samsung Biologics has launched a cash public tender offer to acquire 100% of PolyPeptide Group AG, a leading global contract development and manufacturing organisation...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
